Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 3;103(40):14738-43.
doi: 10.1073/pnas.0604005103. Epub 2006 Sep 26.

Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase

Affiliations

Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase

Lee M Hoffart et al. Proc Natl Acad Sci U S A. .

Abstract

The Fe(II)- and alpha-ketoglutarate (alphaKG)-dependent dioxygenases use mononuclear nonheme iron centers to effect hydroxylation of their substrates and decarboxylation of their cosubstrate, alphaKG, to CO(2) and succinate. Our recent dissection of the mechanism of taurine:alphaKG dioxygenase (TauD), a member of this enzyme family, revealed that two transient complexes accumulate during catalysis in the presence of saturating substrates. The first complex contains the long-postulated C-H-cleaving Fe(IV)-oxo intermediate, J, and the second is an enzyme.product(s) complex. Here, we demonstrate the accumulation of two transient complexes in the reaction of a prolyl-4-hydroxylase (P4H), a functional homologue of human alphaKG-dependent dioxygenases with essential roles in collagen biosynthesis and oxygen sensing. The kinetic and spectroscopic properties of these two P4H complexes suggest that they are homologues of the TauD intermediates. Most notably, the first exhibits optical absorption and Mössbauer spectra similar to those of J and, like J, a large substrate deuterium kinetic isotope on its decay. The close correspondence of the accumulating states in the P4H and TauD reactions supports the hypothesis of a conserved mechanism for substrate hydroxylation by enzymes in this family.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1.
Scheme 1.
Consensus mechanism for oxygen activation by the Fe(II)- and αKG-dependent dioxygenases. The states labeled J and V have been trapped and characterized for TauD (–35) and P4H (this work).
Fig. 1.
Fig. 1.
Spectrophotometrically monitored titration of αKG into a solution of the P4H·Fe(II) complex at 5°C in the absence of O2. The starting protein solution contained 650 μM P4H and 500 μM Fe(II) in P4H buffer (described in Experimental Methods). The spectra shown correspond to αKG concentrations of 0.17 mM (circles), 0.33 mM (squares), 0.54 mM (diamonds), and 0.98 mM (triangles). The points in Inset depict the change of absorbance at 520 nm. The solid line is a fit yielding a Kd of 27 ± 6 μM.
Fig. 2.
Fig. 2.
SF absorption kinetic traces from reactions of P4H·Fe(II)·αKG [±(Pro-Ala-Pro-Lys)3] containing either unlabeled (Pro-Ala-Pro-Lys)3 or deuteriated substrate (d7-Pro-Ala-d7-Pro-Lys)3 with O2. Final reaction conditions were 0.75 mM P4H, 0.50 mM Fe(II), 5 mM αKG, 5 mM ascorbate, 5 mM substrate, and 0.2 mM O2. (Upper) Absorbance at 520 nm for the reactions lacking any peptide substrate (squares) and with (Pro-Ala-Pro-Lys)3 (open circles). The solid line is a fit of the equation given in Experimental Methods to the data. (Lower) Absorbance at 320 nm in the reactions of (Pro-Ala-Pro-Lys)3 (open circles) and (d7-Pro-Ala-d7-Pro-Lys)3 (closed circles). The solid lines are fits, as described in Experimental Methods.
Fig. 3.
Fig. 3.
4.2-K/40-mT Mössbauer spectra of selected samples of P4H. (Left) O2-free P4H·Fe(II)·αKG·(Pro-Ala-Pro-Lys)3 complex (Top) and 20-ms freeze-quenched samples from the reaction of this complex with O2 at 5°C [Middle, deuteriated (d7-Pro-Ala-d7-Pro-Lys)3; Bottom, unlabeled (Pro-Ala-Pro-Lys)3]. The solid line in the middle spectrum is the contribution of the Fe(IV) intermediate (38%) simulated according to the parameters quoted in the text. The solid line in Bottom is the contribution of the P4H·Fe(II)·αKG·(Pro-Ala-Pro-Lys)3 complex (62%). (Right) Comparison of derived spectra of the three accumulating states from the P4H (vertical lines) and TauD (solid lines) catalytic cycles: quaternary complex (Top), Fe(IV) intermediate (Middle), and product(s) complex (Bottom). For the 20-ms samples, the concentrations after mixing were 1.4 mM P4H, 1.25 mM Fe(II), 5 mM αKG, 5 mM ascorbate, 3.3 mM (Pro-Ala-Pro-Lys)3 (unlabeled or deuteriated), and 1.2 mM O2.
Fig. 4.
Fig. 4.
Kinetics of the P4H reaction by SF absorption and FQ Mössbauer. Left, 4.2-K/40-mT Mössbauer spectra of samples quenched at 20 ms, 68 ms, 160 ms, and 370 ms. The solid line in the top spectrum is the derived spectrum of J. Right, Comparison of the deduced concentration of J with the A320 kinetic trace from the SF experiment with identical reaction conditions. Error bars on the concentrations of J deduced from Mössbauer spectra reflect the uncertainty of ±3% of the absorption area of the spectra (ordinate) and the uncertainty of the reaction time of ±5 ms (abscissa). Optimal agreement between concentration and absorbance required Δε320 = 1,500 M−1·cm−1 for the Fe(IV) intermediate. Concentrations were 1 mM P4H, 0.75 mM Fe(II), 5 mM αKG, 5 mM ascorbate, 5 mM (d7-Pro-Ala-d7-Pro-Lys)3, and 0.65 mM O2.
Fig. 5.
Fig. 5.
4.2-K/variable-field Mössbauer spectra of the 20-ms sample from the (d7-Pro-Ala-d7-Pro-Lys)3 reaction shown in Fig. 3. (Left) Experimental spectrum (vertical lines) and spectrum of O2-free control, scaled to 62% of the total intensity (solid line). (Right) Derived spectra of the Fe(IV) intermediate from P4H (vertical lines) and spin Hamiltonian simulations (solid lines) according to the parameters given in Table 1.

References

    1. Solomon EI, Brunold TC, Davis MI, Kemsley JN, Lee S-K, Lehnert N, Neese F, Skulan AJ, Yang Y-S, Zhou J. Chem Rev. 2000;100:235–349. - PubMed
    1. Hausinger RP. Crit Rev Biochem Mol Biol. 2004;39:21–68. - PubMed
    1. Costas M, Mehn MP, Jensen MP, Que L., Jr Chem Rev. 2004;104:939–986. - PubMed
    1. Hanauske-Abel HM, Günzler V. J Theor Biol. 1982;94:421–455. - PubMed
    1. Vaillancourt FH, Yin J, Walsh CT. Proc Natl Acad Sci USA. 2005;102:10111–10116. - PMC - PubMed

Publication types